28th Sep 2005 15:30
28 September 2005Shire Pharmaceuticals Group plc (the "Company")Notification of the Exercise of an Option and Sale of Shares by a PersonDischarging Managerial ResponsibilitiesThe Company announces that on 28 September 2005 it was notified of the exercisein London on the same day by Mr Gregory Flexter, Executive Vice President andGeneral Manager, North America, of an option over 86,466 ordinary 5p shares inthe Company at an exercise price of ‚£5.25.The Company further announces that on 28 September 2005 it was notified of thesale in London on the same day by Mr Flexter of the same 86,466 ordinary 5pshares in the Company at a price of ‚£6.92.Following these transactions, Mr Flexter holds options over 447,088 ordinary 5pshares in the Company.For further information please contact:Investor Relations Clƒ©a Rosenfeld (Rest of the World) +44 1256 894 160 Brian Piper (North America) +1 484 595 8252 Notes to editorsShire Pharmaceuticals Group plcShire Pharmaceuticals Group plc (Shire) is a global specialty pharmaceuticalcompany with a strategic focus on meeting the needs of the specialist physicianand currently focuses on developing and marketing products in the areas ofcentral nervous system (CNS), gastrointestinal (GI), renal diseases and humangenetics. Shire has operations in the world's key pharmaceutical markets (US,Canada, UK, France, Italy, Spain and Germany) as well as a specialist drugdelivery unit in the US.For further information on Shire, please visit the Company's website: www.shire.com. Hampshire International Business Park Chineham Basingstoke Hampshire RG24 8EP United Kingdom Tel +44 (0)1256 894000 Fax +44 (0)1256 894708 www.shire.com Registered in England 2883758 Registered Office as aboveENDShire Pharmaceuticals Group PLCRelated Shares:
Shire